What is testosterone replacement therapy (TRT), and who is medically eligible in Europe?

Testosterone replacement therapy explained: male hypogonadism, low testosterone diagnosis, blood testing criteria, treatment forms, and safety monitoring.

In this episode, we outline how TRT is assessed and prescribed under EU medical guidance.

You’ll learn:

• What hypogonadism is (clinically confirmed low testosterone with symptoms)

• Common symptoms: low libido, fatigue, reduced muscle mass, mood changes

• Why two separate morning testosterone blood tests are required

• Available treatments: gels, injections, and other approved formulations

• Monitoring requirements: haematocrit, PSA, lipid profile, liver function

• Fertility considerations and suppression of sperm production

• Potential risks: erythrocytosis, prostate monitoring, cardiovascular review

• Situations where TRT requests may be declined without confirmed biochemical deficiency

We explain how doctors assess symptom pattern, repeat hormone testing, cardiovascular risk, sleep apnoea risk, prostate history, and fertility plans during an online consultation in the EU. TRT is not prescribed for age-related decline alone without documented deficiency.

This episode reflects the clinical standards used by Mobi Doctor, where hormone-related consultations are reviewed by a registered physician in line with EU prescribing guidance.

Learn more here:

https://www.mobidoctor.eu/testosterone-replacement-therapy